Evaluation of efficacy of diquafosol sodium eyedrop
Not Applicable
- Conditions
- Meibomian gland dysfunction
- Registration Number
- JPRN-UMIN000018510
- Lead Sponsor
- Inouye Eye Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
1. atients who use dry eye or MGD treatment within 2 weeks before a study starts. 2. Patient who have a previous history of treatment intended to become obstructed lacrimal puncta. 3. Patients who need to use eyedrops other than test drugs during a study. 4. Patients who have anatomically and functionally abnormal eyelid. 5. Patients with surgical history in the internal eye (including laser therapy) within 3 months prior to initiation of the clinical research. 6. Patients who have a previous allergy to drugs that they use during a study. 7. Patients who have any other reasons that causes the study doctor to deem a subject unsuitable for the study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. Symptoms 2. Slit lamp 3. Tear film breakup time 4. Meibography 5.Tear volume , Tear thickness
- Secondary Outcome Measures
Name Time Method